SGI

SEC Filing Summary: Tempur-Pedic International Inc. (10-Q)

Business Context and Reporting Period

This Quarterly Report on Form 10-Q covers the period ended March 31, 2005. Tempur-Pedic International Inc. is a vertically-integrated manufacturer and marketer of premium visco-elastic mattresses and pillows, operating primarily under the TEMPUR and Tempur-Pedic brands. The company manufactures products in Denmark and the U.S., selling globally in approximately 60 countries through Retail, Direct, Healthcare, and Third-party distribution channels.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 45% year-over-year, driven primarily by a 65% increase in mattress sales. The Retail channel saw the largest growth (62%), boosted by customers purchasing ahead of a February 2005 price increase.
• Profitability: Net income more than doubled to $26.8 million. Operating income rose 62% to $49.4 million.
• Margin Compression: Gross margin decreased slightly to 51.4% from 53.1%. This was attributed to a shift in product mix toward mattresses (which have lower margins than pillows), increased freight costs from importing inventory from Europe to the U.S., and the rapid growth of the lower-margin Retail channel.
• Debt Reduction: Total debt decreased by approximately $29 million due to the prepayment of European Term A loans ($29.1 million total) on March 31, 2005. This resulted in a $0.7 million loss on extinguishment of debt.
• Capital Expenditures: Investing cash outflows increased significantly to $19.1 million (from $5.0 million), primarily due to $16.1 million spent on the construction of a new manufacturing facility in Albuquerque, New Mexico.

Guidance, Outlook, and Risks

• Outlook: Management expects continued rapid growth but anticipates downward pressure on margins due to the Retail channel expansion and the mix shift to mattresses. The new New Mexico facility is expected to be completed in Q2 2006, which should alleviate current import costs.
• Capital Needs: Total capital expenditures for 2005 are projected at approximately $89.6 million, with $54.6 million allocated to the New Mexico facility.
• Key Risks:
  • Competition: Intense competition from standard innerspring and other foam mattress manufacturers; risk of price wars.
  • Supply Chain: Reliance on two primary suppliers for polyol (a key raw material) and outsourcing of sewing/cutting to Poland and Ukraine.
  • Regulatory: New fire retardancy standards in California and potential changes in U.S. Medicare/Medicaid reimbursement policies for healthcare products.
  • Foreign Exchange: Approximately 33% of sales are denominated in foreign currencies; fluctuations could materially impact results.
  • Product Returns: A 120-day money-back guarantee in the U.S. creates exposure to return rates, which were approximately 6% of U.S. net sales in Q1 2005.

Investor Verification Checklist

• Margin Sustainability: Verify if the shift to lower-margin mattress sales and Retail channel growth will permanently compress gross margins below historical levels.
• Debt Covenants: Confirm continued compliance with financial covenants (interest coverage, leverage ratios) given the high debt load ($260.5 million) relative to equity ($235.9 million).
• Construction Timeline: Monitor the progress and cost overruns of the Albuquerque facility, as delays could impact the ability to meet demand and increase costs.
• Return Rates: Track the 120-day return rate in the U.S. market to ensure it remains within historical estimates and does not erode profitability.
• Raw Material Costs: Assess the impact of polyol price volatility on cost of sales and the company's ability to pass costs to consumers.